Zobrazeno 1 - 6
of 6
pro vyhledávání: '"NATALIA BREYNER"'
Publikováno v:
Diabetes. 71
Introduction: Combination of therapies is a promising strategy for the treatment of NASH and liver fibrosis. Here we evaluated whether the Farnesoid X Receptor agonist obeticholic acid (OCA) combined with the glucagon-like peptide-1 (GLP-1) receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acd408844a41fbf00f3e9f9e8d0661bf
https://doi.org/10.2337/db22-272-or
https://doi.org/10.2337/db22-272-or
Autor:
Sandrine Auger, Camille Kropp, Esther Borras-Nogues, Wasaporn Chanput, Gwenaelle Andre-Leroux, Oscar Gitton-Quent, Leandro Benevides, Natalia Breyner, Vasco Azevedo, Philippe Langella, Jean-Marc Chatel
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 3; Pages: 1705
International Journal of Molecular Sciences, Vol 23, Iss 1705, p 1705 (2022)
International Journal of Molecular Sciences, Vol 23, Iss 1705, p 1705 (2022)
The commensal bacterium Faecalibacterium prausnitzii has unique anti-inflammatory properties, at least some of which have been attributed to its production of MAM, the Microbial Anti-inflammatory Molecule. Previous phylogenetic studies of F. prausnit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc18359c95f7fafe607b2b8bb6c4468
Publikováno v:
Journal of Hepatology. 77:S717
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eb83a29ebbb550baee43fdec4e7f71b
https://doi.org/10.1016/s0168-8278(22)01752-4
https://doi.org/10.1016/s0168-8278(22)01752-4
Autor:
Emmanuel Brousseau, Rémy Burcelin, Thierry Sulpice, Virgile Richard, Mélanie Bouchet, Thierry Leste-Lasserre, Audrey Chabrat, Natalia Breyner, Clément Costard, Mathieu Petitjean, Li Chen, Julie Maupoint, François Briand, Caroline Dubroca
Publikováno v:
Metabolism
Metabolism, Elsevier, 2021, 117, pp.154707. ⟨10.1016/j.metabol.2021.154707⟩
Metabolism, Elsevier, 2021, 117, pp.154707. ⟨10.1016/j.metabol.2021.154707⟩
International audience; Background: Cardiovascular disease is the leading cause of deaths in nonalcoholic steatohepatitis (NASH) patients. Mouse models, while widely used for drug development, do not fully replicate human NASH nor integrate the assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::574d947aeac1a2d75dcf0828dcab61a3
https://hal.archives-ouvertes.fr/hal-03608393/document
https://hal.archives-ouvertes.fr/hal-03608393/document
Autor:
Emmanuel Brousseau, Clément Costard, Rémy Burcelin, Thierry Sulpice, François Briand, Natalia Breyner, Caroline Dubroca, Julie Maupoint
Publikováno v:
European Journal of Pharmacology. 882:173316
Lorcaserin (LORCA) and liraglutide (LIRA) were evaluated in a novel diet-induced obese (DIO) rat model fed a free choice (FC) diet, that presents rats with the options between control chow (CC) or high fat/cholesterol (HFC) diet, and normal water (NW
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6c263d91cc4b57b060ab9e4e4d88690
https://doi.org/10.1016/j.ejphar.2020.173316
https://doi.org/10.1016/j.ejphar.2020.173316